Skip to main content
Log in

Diagnostik und Therapie neuropathischer Schmerzen

Diagnostics and therapy of neuropathic pain

  • Leitthema
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Der neuropathische Schmerz ist ein Schmerz, der durch eine Läsion oder Erkrankung des somatosensorischen Nervensystems verursacht wird. Wissenschaftliche Untersuchungen konnten belegen, dass neuropathische Schmerzen Folge komplex veränderter Signalprozesse im peripheren und im Zentralnervensystem sind. Aktuelle Therapien neuropathischer Schmerzen sind kausal orientiert, haben aber auch symptomatisch die Analgesie durch pharmakologische und nichtpharmakologische Methoden zum Ziel. Weiterhin werden psychologische Schmerzbewältigungstechniken supportiv eingesetzt. Diese Übersicht fasst die zeitgemäße Diagnostik neuropathischer Schmerzen am Beispiel häufiger Erkrankungen zusammen und stellt die Evidenz aus randomisierten kontrollierten Studien zur Therapie neuropathischer Schmerzen vor. Die Behandlungsrichtlinien zur pharmakologischen Beeinflussung neuropathischer Schmerzen umfassen den evidenzbasierten Einsatz von Antidepressiva, Antikonvulsiva, Opioiden, Capsaicin und Lidocain.

Abstract

Neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system. Scientific studies have shown that neuropathic pain is the result of complex altered signalling processes in the peripheral and central nervous system. Current forms of treatment of neuropathic pain are causally oriented but also aim at symptomatic analgesia by pharmacological and nonpharmacological methods. Furthermore, psychological pain management techniques are used in a supportive role. This review summarizes the contemporary diagnostics of neuropathic pain using frequent diseases as examples and presents the evidence from randomized controlled trials on the treatment of neuropathic pain. Treatment guidelines for pharmacological management of neuropathic pain include evidence-based use of antidepressants, anticonvulsants, opioids, capsaicin and lidocaine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Attal N, Bouhassira D, Baron R (2018) Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol 17:456–466

    PubMed  Google Scholar 

  2. Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 17:e1113–e1188

    Google Scholar 

  3. Attal N, De Andrade DC, Adam F et al (2016) Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 15:555–565

    CAS  PubMed  Google Scholar 

  4. Baron R, Maier C, Attal N et al (2017) Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 158:261–272

    PubMed  Google Scholar 

  5. Beloeil H, Sion B, Rousseau C et al (2017) Early postoperative neuropathic pain assessed by the DN4 score predicts an increased risk of persistent postsurgical neuropathic pain. Eur J Anaesthesiol 34:652–657

    PubMed  Google Scholar 

  6. Bendtsen L, Zakrzewska JM, Heinskou TB et al (2020) Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol 19:784–796

    CAS  PubMed  Google Scholar 

  7. Bennett M (2001) The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 92:147–157

    CAS  PubMed  Google Scholar 

  8. Bhaskar A, Bell A, Boivin M et al (2021) Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res 3:22

    PubMed  PubMed Central  Google Scholar 

  9. Bouhassira D, Attal N, Alchaar H et al (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114:29–36

    PubMed  Google Scholar 

  10. Bouhassira D, Lanteri-Minet M, Attal N et al (2008) Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 136:380–387

    PubMed  Google Scholar 

  11. Broggi G, Ferroli P, Franzini A et al (2000) Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 68:59–64

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Casser HR, Huppe M, Kohlmann T et al (2012) German pain questionnaire and standardised documentation with the KEDOQ-Schmerz. A way for quality management in pain therapy. Schmerz 26:168–175

    CAS  PubMed  Google Scholar 

  13. Chaparro LE, Smith SA, Moore RA et al (2013) Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008307.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chen Q, Chen E, Qian X (2021) A narrative review on perioperative pain management strategies in enhanced recovery pathways-the past, present and future. J Clin Med 10(12):2568. https://doi.org/10.3390/jcm10122568

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chen YK, Boden KA, Schreiber KL (2021) The role of regional anaesthesia and multimodal analgesia in the prevention of chronic postoperative pain: a narrative review. Anaesthesia 76(Suppl 1):8–17

    PubMed  PubMed Central  Google Scholar 

  16. Cruccu G, Truini A (2017) A review of neuropathic pain: from guidelines to clinical practice. Pain Ther 6:35–42

    PubMed  PubMed Central  Google Scholar 

  17. De Greef BTA, Hoeijmakers JGJ, Geerts M et al (2019) Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial. Brain 142:263–275

    PubMed  Google Scholar 

  18. Demant DT, Lund K, Vollert J et al (2014) The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. Pain 155:2263–2273

    CAS  PubMed  Google Scholar 

  19. Derry S, Rice AS, Cole P et al (2017) Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007393.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dieleman JP, Kerklaan J, Huygen F et al (2008) Incidence rates and treatment of neuropathic pain conditions in the general population. Pain 137:681–688

    PubMed  Google Scholar 

  21. Dillmann U, Nilges P, Saile H et al (1994) Assessing disability in chronic pain patients. Schmerz 8:100–110

    CAS  Google Scholar 

  22. Farrar JT, Young JP Jr, Lamoreaux L et al (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158

    PubMed  Google Scholar 

  23. Finnerup NB, Attal N, Haroutounian S et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–173

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Finnerup NB, Haroutounian S, Kamerman P et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157:1599–1606

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Fitzcharles MA, Cohen SP, Clauw DJ et al (2021) Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397:2098–2110

    PubMed  Google Scholar 

  26. Forbes HJ, Thomas SL, Smeeth L et al (2016) A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 157:30–54

    PubMed  Google Scholar 

  27. Freynhagen R, Baron R, Gockel U et al (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22:1911–1920

    PubMed  Google Scholar 

  28. Freynhagen R, Parada HA, Calderon-Ospina CA et al (2019) Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin 35:1011–1018

    PubMed  Google Scholar 

  29. Gilron I, Tu D, Holden RR et al (2015) Combination of morphine with nortriptyline for neuropathic pain. Pain 156:1440–1448

    CAS  PubMed  Google Scholar 

  30. Haanpaa M, Attal N, Backonja M et al (2011) NeuPSIG guidelines on neuropathic pain assessment. Pain 152:14–27

    PubMed  Google Scholar 

  31. Hauser W, Bock F, Huppe M et al (2020) Recommendations of the second update of the LONTS guidelines : Long-term opioid therapy for chronic noncancer pain. Schmerz 34:204–244

    PubMed  Google Scholar 

  32. Holbech JV, Bach FW, Finnerup NB et al (2015) Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial. Pain 156:958–966

    CAS  PubMed  Google Scholar 

  33. Ihs (2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1–211

    Google Scholar 

  34. Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126

    PubMed  Google Scholar 

  35. Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625

    PubMed  Google Scholar 

  36. Knorr JP, Barlow A, Reinaker TS et al (2021) A single dose of pre-operative pregabalin reduces post-operative opioid use after orthotopic liver transplantation. Clin Transplant 35(7):e14319. https://doi.org/10.1111/ctr.14319

    Article  CAS  PubMed  Google Scholar 

  37. Kuiken TA, Schechtman L, Harden RN (2005) Phantom limb pain treatment with mirtazapine: a case series. Pain Pract 5:356–360

    PubMed  Google Scholar 

  38. Labau JIR, Estacion M, Tanaka BS et al (2020) Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy. Brain 143:771–782

    PubMed  PubMed Central  Google Scholar 

  39. Lutz J, Thon N, Stahl R et al (2016) Microstructural alterations in trigeminal neuralgia determined by diffusion tensor imaging are independent of symptom duration, severity, and type of neurovascular conflict. J Neurosurg 124:823–830

    PubMed  Google Scholar 

  40. Maarbjerg S, Benoliel R (2021) The changing face of trigeminal neuralgia—A narrative review. Headache 61:817–837

    PubMed  Google Scholar 

  41. Moisset X, Bouhassira D, Avez Couturier J et al (2020) Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations. Rev Neurol 176:325–352

    CAS  PubMed  Google Scholar 

  42. Moulin D, Boulanger A, Clark AJ et al (2014) Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag 19:328–335

    PubMed  PubMed Central  Google Scholar 

  43. Mu A, Weinberg E, Moulin DE et al (2017) Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement. Can Fam Physician 63:844–852

    PubMed  PubMed Central  Google Scholar 

  44. Mucke M, Phillips T, Radbruch L et al (2018) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd012182.pub2

    Article  PubMed  PubMed Central  Google Scholar 

  45. Nilges P, Essau C (2015) Depression, anxiety and stress scales: DASS—A screening procedure not only for pain patients. Schmerz 29:649–657

    CAS  PubMed  Google Scholar 

  46. Nishihara M, Arai YCP, Yamamoto Y et al (2013) Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Phys 16:E547–E552

    Google Scholar 

  47. Ostgathe C, Voltz R, Van Aaaken A et al (2012) Practicability, safety, and efficacy of a „German model“ for opioid conversion to oral levo-methadone. Support Care Cancer 20:2105–2110

    PubMed  Google Scholar 

  48. Petzke F, Hüppe M, Kohlmann T, Kükens-Höner S, Lindena G, Pfingsten M, Nagel N (2020) Handbuch Deutscher Schmerz-Fragebogen. https://www.schmerzgesellschaft.de/fileadmin/user_upload/DSF-Handbuch_2020.pdf. Zugegriffen: 07.05.2021

  49. Petzke F, Karst M, Gastmeier K et al (2019) Position paper on medical cannabis and cannabis-based medicines in pain medicine. Schmerz 33:449–465

    PubMed  Google Scholar 

  50. Pickering G, Lucchini C (2020) Topical treatment of localized neuropathic pain in the elderly. Drugs Aging 37:83–89

    PubMed  Google Scholar 

  51. Pogatzki-Zahn E (2021) Prediction and prevention of chronic postoperative pain. Schmerz 35:30–43

    PubMed  Google Scholar 

  52. Robertson K, Marshman LAG, Plummer D et al (2019) Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial. JAMA Neurol 76:28–34

    PubMed  Google Scholar 

  53. Rolke R, Baron R, Maier C et al (2006) Quantitative sensory testing in the German research network on neuropathic pain (DFNS): standardized protocol and reference values. Pain 123:231–243

    CAS  PubMed  Google Scholar 

  54. Schlereth T (2020) Guideline „diagnosis and non interventional therapy of neuropathic pain“ of the German Society of Neurology (deutsche Gesellschaft fur Neurologie). Neurol Res Pract 2:16

    PubMed  PubMed Central  Google Scholar 

  55. Tait RC, Chibnall JT, Krause S (1990) The pain disability index: psychometric properties. Pain 40:171–182

    PubMed  Google Scholar 

  56. Tomasello F, Esposito F, Abbritti RV, Angileri FF, Conti A, Cardali SM, La Torre D (2016) Microvascular decompression for trigeminal neuralgia: technical refinement for complication avoidance. World Neurosurg 94:26–31

    PubMed  Google Scholar 

  57. Van Seventer R, Vos C, Meerding W et al (2010) Linguistic validation of the DN4 for use in international studies. Eur J Pain 14:58–63

    PubMed  Google Scholar 

  58. Vollert J, Magerl W, Baron R et al (2018) Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models. Pain 159:1090–1102

    PubMed  Google Scholar 

  59. Weinstein EJ, Levene JL, Cohen MS et al (2018) Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007105.pub3

    Article  PubMed  PubMed Central  Google Scholar 

  60. Ziegler D (2008) Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev 24(Suppl 1):S52–S57

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Gossrau.

Ethics declarations

Interessenkonflikt

G. Gossrau und R. Sabatowski geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gossrau, G., Sabatowski, R. Diagnostik und Therapie neuropathischer Schmerzen. Anaesthesist 70, 993–1002 (2021). https://doi.org/10.1007/s00101-021-01039-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-021-01039-x

Schlüsselwörter

Keywords

Navigation